Antibody responses to SARS-CoV-2 infection are attenuated in infliximab-treated patients with IBD.
Nat Rev Gastroenterol Hepatol
; 18(5): 286, 2021 05.
Article
in English
| MEDLINE | ID: covidwho-1387373
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
SARS-CoV-2
/
COVID-19
Limits:
Humans
Language:
English
Journal:
Nat Rev Gastroenterol Hepatol
Journal subject:
Gastroenterology
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS